• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险健康维护组织中患有帕金森病的老年参保者的药物依从性及相关结果

Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.

作者信息

Kulkarni Amit S, Balkrishnan Rajesh, Anderson Roger T, Edin Heather M, Kirsch Jeff, Stacy Mark A

机构信息

Department of Pharmacy Practice and Administration, The Ohio State University, Columbus, Ohio 43210, USA.

出版信息

Mov Disord. 2008 Feb 15;23(3):359-65. doi: 10.1002/mds.21831.

DOI:10.1002/mds.21831
PMID:18074366
Abstract

Maintenance of symptom control in Parkinson's disease (PD) requires continuous titration of medication and addition of multiple therapies over the course of the disease. Adherence to medication is vital to symptom control and key to maximizing the efficacy of existing therapies. However, adherence is compromised by a variety of factors, including motor symptoms, complex dosing regimens, multiple medications, and lack of patient/physician awareness of the impact and prevalence of suboptimal adherence. This retrospective, longitudinal cohort study assessed the prevalence of suboptimal adherence [measured as the medication possession ratio (MPR)] to PD medications, and its impact on the worsening of PD symptoms (measured as increase in monotherapy dose, augmentation of therapy, PD-related emergency department visit, or hospitalization), in a Medicare Health Maintenance Organization population in the United States. Irrespective of the MPR threshold chosen, a high percentage of patients were categorized as suboptimally adherent to their PD medications, and patients with suboptimal adherence to their PD medications had higher risks of worsening of PD symptoms, compared with those who were adherent. Increased awareness of both the magnitude and impact of suboptimal adherence to PD medications, coupled with dosage simplification and a unified effort by healthcare professionals and patients, may improve adherence to PD medications and ultimately improve symptom control.

摘要

帕金森病(PD)症状控制的维持需要在疾病过程中持续调整药物剂量并增加多种治疗方法。坚持服药对症状控制至关重要,也是使现有治疗方法疗效最大化的关键。然而,多种因素会影响服药依从性,包括运动症状、复杂的给药方案、多种药物以及患者/医生对依从性欠佳的影响和普遍性缺乏认识。这项回顾性纵向队列研究评估了美国医疗保险健康维护组织人群中帕金森病药物依从性欠佳(以药物持有率(MPR)衡量)的患病率,及其对帕金森病症状恶化(以单药治疗剂量增加、治疗强化、帕金森病相关急诊就诊或住院衡量)的影响。无论选择何种MPR阈值,都有很大比例的患者被归类为帕金森病药物依从性欠佳,与依从的患者相比,帕金森病药物依从性欠佳的患者帕金森病症状恶化的风险更高。提高对帕金森病药物依从性欠佳的程度和影响的认识,同时简化给药剂量,并由医疗保健专业人员和患者共同努力,可能会提高帕金森病药物的依从性,并最终改善症状控制。

相似文献

1
Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.医疗保险健康维护组织中患有帕金森病的老年参保者的药物依从性及相关结果
Mov Disord. 2008 Feb 15;23(3):359-65. doi: 10.1002/mds.21831.
2
Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.帕金森病患者用药不依从的流行率和费用:来自行政索赔数据的证据。
Mov Disord. 2010 Mar 15;25(4):474-80. doi: 10.1002/mds.22999.
3
Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.帕金森病医疗保险部分 D 受益人与抗帕金森病药物使用和依从性。
Clin Ther. 2013 Oct;35(10):1513-1525.e1. doi: 10.1016/j.clinthera.2013.09.001.
4
Antiparkinson drug adherence and its association with health care utilization and economic outcomes in a Medicare Part D population.在 Medicare Part D 人群中,抗帕金森药物的依从性及其与医疗保健利用和经济结果的关系。
Value Health. 2014 Mar;17(2):196-204. doi: 10.1016/j.jval.2013.12.003.
5
Adherence to antiparkinson medication in a multicenter European study.一项欧洲多中心研究中帕金森病患者对抗帕金森药物的依从性
Mov Disord. 2009 Apr 30;24(6):826-32. doi: 10.1002/mds.22112.
6
Drug therapies for Parkinson's disease: A database analysis of patient compliance and persistence.帕金森病的药物治疗:患者依从性和持续性的数据库分析
Am J Geriatr Pharmacother. 2010 Aug;8(4):374-83. doi: 10.1016/j.amjopharm.2010.08.001.
7
Suboptimal medication adherence in Parkinson's disease.帕金森病中药物依从性欠佳的情况。
Mov Disord. 2005 Nov;20(11):1502-7. doi: 10.1002/mds.20602.
8
Patient-reported autonomic symptoms in Parkinson disease.帕金森病患者自述的自主神经症状。
Neurology. 2007 Jul 24;69(4):333-41. doi: 10.1212/01.wnl.0000266593.50534.e8.
9
Reoperation for suboptimal outcomes after deep brain stimulation surgery.针对脑深部电刺激手术效果欠佳进行的再次手术。
Neurosurgery. 2008 Oct;63(4):754-60; discussion 760-1. doi: 10.1227/01.NEU.0000325492.58799.35.
10
Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease.帕金森病患者中罗匹尼罗24小时缓释制剂与罗匹尼罗速释制剂的药代动力学和药效学比较。
Clin Neuropharmacol. 2009 May-Jun;32(3):140-8. doi: 10.1097/WNF.0B013E318176C505.

引用本文的文献

1
Outpatient interface challenges for drug safety in Parkinson's disease patients: a questionnaire based cross-sectional study.帕金森病患者药物安全的门诊界面挑战:一项基于问卷调查的横断面研究。
Front Neurol. 2025 Jun 19;16:1563636. doi: 10.3389/fneur.2025.1563636. eCollection 2025.
2
Systematic review of wearables assessing medication effect on motor function and symptoms in Parkinson's disease.关于可穿戴设备评估药物对帕金森病运动功能和症状影响的系统评价。
NPJ Parkinsons Dis. 2025 May 22;11(1):135. doi: 10.1038/s41531-025-00943-y.
3
Adherence and persistence with istradefylline treatment in patients with Parkinson's disease in the United States.
美国帕金森病患者对异他司特治疗的依从性和持续性。
Front Pharmacol. 2025 May 6;16:1548631. doi: 10.3389/fphar.2025.1548631. eCollection 2025.
4
A Qualitative Study on Perspectives of Parkinson's Disease Medications: Insights from Patient Focus Groups.帕金森病药物治疗观点的定性研究:来自患者焦点小组的见解
Patient Prefer Adherence. 2024 Sep 18;18:1919-1928. doi: 10.2147/PPA.S473991. eCollection 2024.
5
Adherence to Parkinson's disease medication: A case study to illustrate reasons for non-adherence, implications for practice and engaging under-represented participants in research.帕金森病药物治疗的依从性:一个案例研究,以说明不依从的原因、对实践的影响以及让代表性不足的参与者参与研究的情况。
Explor Res Clin Soc Pharm. 2024 May 7;14:100450. doi: 10.1016/j.rcsop.2024.100450. eCollection 2024 Jun.
6
Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records.帕金森病患者的药物依从性和医疗费用:一项基于电子病历的观察性研究。
BMC Public Health. 2024 Apr 30;24(1):1202. doi: 10.1186/s12889-024-18431-y.
7
Translating digital healthcare to enhance clinical management: a protocol for an observational study using a digital health technology system to monitor medication adherence and its effect on mobility in people with Parkinson's.将数字医疗转化为增强临床管理:一项使用数字健康技术系统监测帕金森病患者药物依从性及其对移动能力影响的观察性研究方案。
BMJ Open. 2023 Sep 4;13(9):e073388. doi: 10.1136/bmjopen-2023-073388.
8
Using the theoretical domains framework to determine the barriers and facilitators to medication adherence in Parkinson's disease.运用理论领域框架确定帕金森病药物治疗依从性的障碍因素和促进因素。
Explor Res Clin Soc Pharm. 2023 Jul 13;11:100309. doi: 10.1016/j.rcsop.2023.100309. eCollection 2023 Sep.
9
Long-acting injectable in situ gel of rasagiline: a patented product development.雷沙吉兰长效原位注射凝胶:专利产品研发。
Drug Deliv Transl Res. 2023 Apr;13(4):1012-1021. doi: 10.1007/s13346-022-01261-z. Epub 2022 Dec 27.
10
Factors related to barriers and medication adherence in patients with type 2 diabetes mellitus: a cross-sectional study.2型糖尿病患者中与障碍及药物依从性相关的因素:一项横断面研究
J Diabetes Metab Disord. 2022 Jan 29;21(1):219-228. doi: 10.1007/s40200-021-00961-6. eCollection 2022 Jun.